$159.33
1.43%
NYSE, Oct 16, 04:27 pm EDT. Closed.
ISIN
US7427181091
Symbol
PG

Procter & Gamble Target price 2026 - Analyst rating & recommendation

Procter & Gamble Classifications & Recommendation

Buy
51%
Hold
46%
Sell
3%

Procter & Gamble Price Target

Target Price $163.20
Price $159.35
Potential 2.42%
Number of Estimates 30
30 Analysts have issued a price target Procter & Gamble 2027 . The average Procter & Gamble target price is $163.20. This is 2.42% higher than the current stock price. The highest price target is $195.30 22.56% , the lowest is $144.43 9.36% .
A rating was issued by 37 analysts: 19 Analysts recommend Procter & Gamble to buy, 17 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2027 of 2.42% . Most analysts recommend the Procter & Gamble stock at Purchase.

Sales and Margin forecast 2027, 2028 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Revenue Billion $ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

30 Analysts have issued a sales forecast Procter & Gamble 2027 . The average Procter & Gamble sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2026 $87.0b 3.26%
2027
2028
2029
2030
2031
2032
2033

25 Analysts have issued an Procter & Gamble EBITDA forecast 2027. The average Procter & Gamble EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 $24.0b 1.50%
2027
2028
2029
2030
2031
2032
2033

EBITDA Margin

2026 27.55% 1.70%
2027
2028
2029
2030
2031
2032
2033

31 Procter & Gamble Analysts have issued a net profit forecast 2027. The average Procter & Gamble net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 $15.8b 0.46%
2027
2028
2029
2030
2031
2032
2033

Net Margin

2026 18.10% 2.71%
2027
2028
2029
2030
2031
2032
2033

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Earnings Per Share $ ??? ???
??? ???
P/E ???
EV/Sales ???

31 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is

. This is than earnings per share in the financial year 2026. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 $6.50 1.88%
2027
2028
2029
2030
2031
2032
2033

P/E ratio

Current 24.44 4.66%
2027
2028
2029
2030
2031
2032
2033

Based on analysts' sales estimates for 2027, the Procter & Gamble stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.53 1.80%
2027
2028
2029
2030
2031
2032
2033

P/S ratio

Current 4.25 2.31%
2027
2028
2029
2030
2031
2032
2033

Current Procter & Gamble Upgrades & Downgrades

Analyst Rating Action Date
Citigroup
Buy
➜
Buy
Unchanged Oct 14 2026
Evercore ISI Group
In-Line
➜
Outperform
Upgrade Oct 06 2026
RBC Capital
Outperform
➜
Outperform
Unchanged Oct 06 2026
TD Cowen
Hold
➜
Hold
Unchanged Sep 30 2026
Argus Research
Buy
➜
Hold
Downgrade Aug 07 2026
HSBC
Buy
➜
Hold
Downgrade Jul 30 2026
Citigroup
Buy
➜
Buy
Unchanged Jul 30 2026
Analyst Rating Date
Unchanged
Citigroup:
Buy
➜
Buy
Oct 14 2026
Upgrade
Evercore ISI Group:
In-Line
➜
Outperform
Oct 06 2026
Unchanged
RBC Capital:
Outperform
➜
Outperform
Oct 06 2026
Unchanged
TD Cowen:
Hold
➜
Hold
Sep 30 2026
Downgrade
Argus Research:
Buy
➜
Hold
Aug 07 2026
Downgrade
HSBC:
Buy
➜
Hold
Jul 30 2026
Unchanged
Citigroup:
Buy
➜
Buy
Jul 30 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today